Literature DB >> 10831482

Relation of familial schizophrenia to negative symptoms but not to the deficit syndrome.

D Malaspina1, R R Goetz, S Yale, A Berman, J H Friedman, F Tremeau, D Printz, X Amador, J Johnson, A Brown, J M Gorman.   

Abstract

OBJECTIVE: Although a family history of schizophrenia has been associated with negative symptoms, family history is inconsistently related to the presence of the deficit syndrome.
METHOD: The authors assessed family history and the deficit syndrome in 99 patients with DSM-III-R-diagnosed schizophrenia who were assessed during clinical treatment. Of these 99 patients, 45 were assessed both while antipsychotic free and during antipsychotic treatment to index their treatment response.
RESULTS: Patients with (N=39) and without (N=60) a family history of schizophrenia had similar proportions of the deficit syndrome. Yet family history and deficit syndrome categorizations identified a group with greater negative symptoms on the Positive and Negative Syndrome Scale. Those with a family history had greater emotional withdrawal, poor rapport, and lack of spontaneity. Groups with and without the deficit syndrome similarly differed in these symptoms but also in affective blunting, motor retardation, and passive or apathetic social withdrawal. The study involving antipsychotic-free and antipsychotic treatment phases showed main medication effects explaining positive, psychopathology, depression, and activation symptoms but not negative symptoms. Only patients without a family history had improved negative symptoms with antipsychotic treatment.
CONCLUSIONS: Patients with a family history of schizophrenia had greater and more treatment-resistant negative symptoms than those without a family history. They were not more likely to have the deficit syndrome. The group with a family history had more pathology only in negative symptoms related to psychosocial function. The stable negative symptoms specifically related to the genetic vulnerability to inherit schizophrenia might be those associated with psychosocial functioning.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10831482     DOI: 10.1176/appi.ajp.157.6.994

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  20 in total

Review 1.  Paternal factors and schizophrenia risk: de novo mutations and imprinting.

Authors:  D Malaspina
Journal:  Schizophr Bull       Date:  2001       Impact factor: 9.306

2.  Evaluation of familial influences on the course and severity of schizophrenia among US and Indian cases.

Authors:  Smita N Deshpande; Triptish Bhatia; Joel Wood; Jaspreet S Brar; B K Thelma; Rohan Ganguli; Richard Day; Irving I Gottesman; Vishwajit L Nimgaonkar
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2004-05       Impact factor: 4.328

Review 3.  rTMS strategies for the study and treatment of schizophrenia: a review.

Authors:  Arielle D Stanford; Zafar Sharif; Cheryl Corcoran; Nina Urban; Dolores Malaspina; Sarah H Lisanby
Journal:  Int J Neuropsychopharmacol       Date:  2008-02-01       Impact factor: 5.176

4.  Ethnicity effects on clinical diagnoses compared to best-estimate research diagnoses in patients with psychosis: a retrospective medical chart review.

Authors:  Deidre M Anglin; Dolores Malaspina
Journal:  J Clin Psychiatry       Date:  2008-06       Impact factor: 4.384

5.  Odor identification, eye tracking and deficit syndrome schizophrenia.

Authors:  Dolores Malaspina; Eliza Coleman; Raymond R Goetz; Jill Harkavy-Friedman; Cheryl Corcoran; Xavier Amador; Scott Yale; Jack M Gorman
Journal:  Biol Psychiatry       Date:  2002-05-15       Impact factor: 13.382

6.  Family history of psychosis negatively impacts age at onset, negative symptoms, and duration of untreated illness and psychosis in first-episode psychosis patients.

Authors:  Michelle Esterberg; Michael Compton
Journal:  Psychiatry Res       Date:  2012-04-14       Impact factor: 3.222

7.  The impact of family experience on the duration of untreated psychosis (DUP) in Hong Kong.

Authors:  Eric Yu-Hai Chen; Eva Lai-Wah Dunn; May Yin-King Miao; Wai-Song Yeung; Chi-Keung Wong; Wah-Fat Chan; Ronald Yuk-Lun Chen; Ka-Fai Chung; Wai-Nang Tang
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2005-05       Impact factor: 4.328

Review 8.  Treatment resistant schizophrenia: Clinical, biological, and therapeutic perspectives.

Authors:  Frederick C Nucifora; Edgar Woznica; Brian J Lee; Nicola Cascella; Akira Sawa
Journal:  Neurobiol Dis       Date:  2018-08-29       Impact factor: 5.996

9.  High-frequency prefrontal repetitive transcranial magnetic stimulation for the negative symptoms of schizophrenia: a case series.

Authors:  Arielle D Stanford; Cheryl Corcoran; Peter Bulow; Sarah Bellovin-Weiss; Dolores Malaspina; Sarah H Lisanby
Journal:  J ECT       Date:  2011-03       Impact factor: 3.635

10.  Atrophy of basal ganglia nuclei and negative symptoms in temporal lobe epilepsy.

Authors:  Elizabeth K Geary; Michael Seidenberg; Bruce Hermann
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2009       Impact factor: 2.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.